Ignite Creation Date:
2024-05-06 @ 9:45 AM
Last Modification Date:
2024-10-26 @ 12:19 PM
Study NCT ID:
NCT03066661
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2019-04-26
First Post:
2017-02-23
Brief Title:
Expanded Access to Entrectinib for Cancers With NTRK123 ROS1 or ALK Gene Fusions
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cancers With NTRK ROS1 or ALK Gene Fusions |
Keywords: